Untested COVID-19 vaccine, Sputnik V, begins 40,000-person trial next week
Russia skipped trials to grant approval and claim breakthrough.
Full Article
Untested COVID-19 vaccine, Sputnik V, begins 40,000-person trial next week
Ars Technica
0 shares
1 views